QinetiQ Group plc (QQ) is a leading aerospace and defence business based in the UK. It opened the day at 355.2p after a previous close of 346.8p. During the day the price has varied from a low of 347.4p to a high of 356p. The latest price was 353.6p (25 minute delay). QinetiQ Group is listed on the London Stock Exchange (LSE) and employs 6,890 staff. All prices are listed in pence sterling.
Best for
US shares
Best for
Low-cost
Best for
Beginners
Best for
Range of stock exchanges
Since the stock market crash that started in February 2020, QinetiQ Group's share price has had significant negative movement.
Its last market close was 323.6p, which is 16.55% down on its pre-crash value of 387.8p and 39.00% up on the lowest point reached during the March 2020 crash when the shares fell as low as 232.8p.
If you had bought £1,000 worth of QinetiQ Group shares at the start of February 2020, those shares would have been worth £759.12 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £908.47.
| Open | 355.2p |
|---|---|
| High | 356p |
| Low | 347.4p |
| Close | 353.6p |
| Previous close | 346.8p |
| Change | 6.8p |
| Change % | 1.9608% |
| Volume | 518,947 |
| 52-week range | 234.1516p - 364.3489p |
|---|---|
| 50-day moving average | 336.5222p |
| 200-day moving average | 336.0972p |
| Wall St. target price | 289.25p |
| PE ratio | 15.4722 |
| Dividend yield | 6.9p (2.1%) |
| Earnings per share (TTM) | 21.6p |
Other fees apply. Your capital is at risk.
Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | No minimum | £0.00 £353.60 total |
Capital at risk |
|
£0 | $50 | £0.00 £353.60 total |
Capital at risk |
 |
£0 | No minimum | £0.00 £353.60 total |
Capital at risk |
 |
£0 | £0.01 | £1.80 £355.40 total |
Capital at risk |
|
£0 | £1 | £11.95 £365.55 total |
Capital at risk |
 |
£9.99 per month | No minimum | £7.99 £361.59 total |
Capital at risk |
 |
£36 per year | £20 | £9.50 £363.10 total |
Capital at risk |
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of 353.6p
| 1 week (2021-09-15) | 8.80% |
|---|---|
| 1 month (2021-08-20) | 5.74% |
| 3 months (2021-06-22) | 1.20% |
| 6 months (2021-03-22) | 5.80% |
| 1 year (2020-09-22) | 38.45% |
|---|---|
| 2 years (2019-09-20) | 18.34% |
| 3 years (2018-09-21) | 23.90% |
| 5 years (2016-09-22) | 49.58% |
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
QinetiQ Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, QinetiQ Group shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
QinetiQ Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £190.6 million.
The EBITDA is a measure of a QinetiQ Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | £1.3 billion |
|---|---|
| Operating margin TTM | 10.97% |
| Gross profit TTM | £193.5 million |
| Return on assets TTM | 5.99% |
| Return on equity TTM | 14.04% |
| Profit margin | 9.74% |
| Book value | 1.562p |
| Market capitalisation | £1.9 billion |
TTM: trailing 12 months
Dividend yield: 2.1% of stock value
Forward annual dividend yield: 2.1% of stock value
Dividend payout ratio: 51.36% of net profits
QinetiQ Group has recently paid out dividends equivalent to 2.10% of its share value annually.
QinetiQ Group has paid out, on average, around 51.36% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.1% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 2.1% return on their shares, in the form of dividend payments. In QinetiQ Group's case, that would currently equate to about 6.9p per share.
QinetiQ Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 29 July 2021 (the "ex-dividend date").
Over the last 12 months, QinetiQ Group's shares have ranged in value from as little as 234.1516p up to 364.3489p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while QinetiQ Group's is 0.6408. This would suggest that QinetiQ Group's shares are less volatile than average (for this exchange).
Subscribe to trending stock alerts for a chance to win
Ever wondered how to buy shares in Rocket Lab USA? We explain how and compare a range of providers that can give you access to many brands, including Rocket Lab USA.
Ever wondered how to buy shares in Camber Energy? We explain how and compare a range of providers that can give you access to many brands, including Camber Energy.
Ever wondered how to buy shares in Aterian? We explain how and compare a range of providers that can give you access to many brands, including Aterian.
Ever wondered how to buy shares in eFFECTOR Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including eFFECTOR Therapeutics.
Ever wondered how to buy shares in Santhera Pharmaceuticals Holding AG? We explain how and compare a range of providers that can give you access to many brands, including Santhera Pharmaceuticals Holding AG.
Ever wondered how to buy shares in Basilea Pharmaceutica? We explain how and compare a range of providers that can give you access to many brands, including Basilea Pharmaceutica.
Ever wondered how to buy shares in AB Science S.A.? We explain how and compare a range of providers that can give you access to many brands, including AB Science.
Ever wondered how to buy shares in Acacia Pharma Group? We explain how and compare a range of providers that can give you access to many brands, including Acacia Pharma Group.
Ever wondered how to buy shares in Blue Water Acquisition? We explain how and compare a range of providers that can give you access to many brands, including Blue Water Acquisition.
Learn more about Aditxt’s recent performance and where you can invest in Aditxt shares. We also run through some helpful rules of thumb for any investor.
